Amaury Daste
4PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 09, 2026
Phase 1b study of ABBV-368, tilsotolimod, budigalimab, and nab-paclitaxel in patients with recurrent/metastatic head and neck squamous cell carcinoma.Amaury Daste, Xiuning Le, Amani Makkouk
|Dec 22, 2025
INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.Danny Rischin, Aaron R Hansen, Ezra E W Cohen
|Dec 21, 2023
Immunotherapy for head and neck squamous cell carcinoma: current status and perspectives.Amaury Daste, Mathieu Larroquette, Nyere Gibson
|Jun 03, 2021
Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME.Thomas Chevalier, Amaury Daste, Esmaa Saada-Bouzid
Pageof 1
Frequent Collaborators
1 joint publications
Thomas Chevalier
1 joint publications
Florence Huguet
1 joint publications
Charlotte Domblides
1 joint publications
Danny Rischin
1 joint publications
Aaron R Hansen
1 joint publications
Ezra E W Cohen
1 joint publications
Makoto Tahara
1 joint publications
Kevin J Harrington
1 joint publications
Robert I Haddad
1 joint publications
Lisa Licitra
